Effect of Reciprocal Electrical Stimulation on Balance and Quality of Life in Hemiparetic CP

NCT07599267 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-05-20

No results posted yet for this study

Summary

to investigate the effect of the reciprocal neuromuscular electrical stimulation on balance and quality of life in hemiparetic children

Conditions

  • Hemiparetic Cerebral Palsy

Interventions

OTHER

reciprocal electrical stimulation

Mode (A) is selected to apply reciprocal neuromuscular electrical stimulation

OTHER

physical therapy program

* neurodevelopmental approach directed toward inhibiting abnormal muscle tone and abnormal reflexes and facilitation of postural control through reflex inhibiting positions using proximal and distal key points of control. * training for active trunk extension to improve posture control and balance . * Balance training from different positions ,from the quadruped position, kneeling ,half kneeling and standing position on mat and tilting board. * facilitation of protective reactions by applying a fast and large amplitude of stimulus to train saving reactions from sitting on roll and also from standing position by pushing the child to encourage the child to take protective steps either forward , backward .or sideways to regain balance. * approximation as a proprioceptive training applied in a slow and rhythmic manner for the upper limbs ,lower limbs , and trunk to control spasticity and stimulate the joint mechanoreceptors from semi reclined and quadruped positions.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-20
Primary Completion
2026-08-01
Completion
2026-09-15
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07599267 on ClinicalTrials.gov